 Barry Rumack
Concepts (684)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acetaminophen | 64 | 2024 | 237 | 9.420 |
Why?
| | Analgesics, Non-Narcotic | 19 | 2024 | 117 | 6.320 |
Why?
| | Chemical and Drug Induced Liver Injury | 30 | 2024 | 125 | 5.520 |
Why?
| | Acetylcysteine | 34 | 2024 | 142 | 4.680 |
Why?
| | Drug Overdose | 26 | 2024 | 293 | 4.220 |
Why?
| | Antidotes | 23 | 2024 | 135 | 2.800 |
Why?
| | Poisoning | 25 | 2012 | 110 | 1.280 |
Why?
| | Nomograms | 4 | 2019 | 41 | 1.140 |
Why?
| | Antiemetics | 1 | 2024 | 32 | 0.900 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 2 | 2023 | 242 | 0.900 |
Why?
| | Poisons | 1 | 2023 | 21 | 0.870 |
Why?
| | Poison Control Centers | 16 | 2012 | 84 | 0.800 |
Why?
| | Alanine Transaminase | 8 | 2022 | 140 | 0.770 |
Why?
| | Canada | 5 | 2023 | 322 | 0.740 |
Why?
| | End Stage Liver Disease | 1 | 2021 | 73 | 0.680 |
Why?
| | Liver | 23 | 2023 | 1681 | 0.650 |
Why?
| | Humans | 200 | 2024 | 115038 | 0.620 |
Why?
| | Cyanides | 9 | 1993 | 46 | 0.540 |
Why?
| | Anaphylaxis | 1 | 2018 | 148 | 0.500 |
Why?
| | Decision Support Techniques | 1 | 2019 | 351 | 0.500 |
Why?
| | Nonprescription Drugs | 4 | 2008 | 68 | 0.460 |
Why?
| | Free Radical Scavengers | 2 | 2012 | 78 | 0.430 |
Why?
| | Sodium Nitrite | 7 | 1997 | 37 | 0.420 |
Why?
| | Mushroom Poisoning | 4 | 2019 | 5 | 0.410 |
Why?
| | Charcoal | 12 | 1999 | 22 | 0.410 |
Why?
| | Adult | 71 | 2023 | 30654 | 0.400 |
Why?
| | Iatrogenic Disease | 1 | 2012 | 50 | 0.390 |
Why?
| | Retrospective Studies | 14 | 2023 | 12547 | 0.390 |
Why?
| | Medication Errors | 1 | 2012 | 89 | 0.380 |
Why?
| | Plant Poisoning | 6 | 1988 | 9 | 0.380 |
Why?
| | Adolescent | 42 | 2020 | 17862 | 0.370 |
Why?
| | Male | 86 | 2022 | 55729 | 0.360 |
Why?
| | Environmental Exposure | 7 | 2012 | 377 | 0.350 |
Why?
| | Protective Agents | 2 | 2020 | 38 | 0.330 |
Why?
| | Nasal Decongestants | 1 | 2008 | 8 | 0.330 |
Why?
| | Cytochrome P-450 CYP2E1 | 4 | 2023 | 27 | 0.330 |
Why?
| | Multicenter Studies as Topic | 3 | 2024 | 250 | 0.320 |
Why?
| | Common Cold | 1 | 2008 | 12 | 0.320 |
Why?
| | Time Factors | 21 | 2021 | 6141 | 0.320 |
Why?
| | Antitussive Agents | 1 | 2008 | 8 | 0.320 |
Why?
| | Alcohol Drinking | 2 | 2012 | 655 | 0.310 |
Why?
| | Nitrites | 5 | 1989 | 74 | 0.310 |
Why?
| | Cough | 1 | 2008 | 107 | 0.300 |
Why?
| | Female | 73 | 2022 | 59610 | 0.270 |
Why?
| | Child | 41 | 2023 | 18407 | 0.270 |
Why?
| | Hepatocytes | 4 | 2022 | 196 | 0.270 |
Why?
| | Hyperbaric Oxygenation | 5 | 1991 | 36 | 0.270 |
Why?
| | Hydrogen Sulfide | 3 | 1997 | 40 | 0.270 |
Why?
| | Infant | 36 | 2012 | 7945 | 0.260 |
Why?
| | Child, Preschool | 38 | 2014 | 9093 | 0.260 |
Why?
| | Young Adult | 9 | 2023 | 10498 | 0.250 |
Why?
| | Databases, Factual | 6 | 2019 | 1132 | 0.250 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 3 | 2020 | 144 | 0.240 |
Why?
| | Administration, Oral | 10 | 2019 | 730 | 0.240 |
Why?
| | Ethanol | 9 | 2012 | 548 | 0.240 |
Why?
| | Pain | 2 | 2020 | 709 | 0.240 |
Why?
| | Ibuprofen | 3 | 1992 | 73 | 0.240 |
Why?
| | Risk Assessment | 3 | 2024 | 2976 | 0.230 |
Why?
| | Potassium Cyanide | 3 | 1989 | 18 | 0.230 |
Why?
| | Infusions, Intravenous | 5 | 2019 | 372 | 0.230 |
Why?
| | Plants, Medicinal | 3 | 1989 | 19 | 0.230 |
Why?
| | Aspirin | 8 | 1989 | 324 | 0.230 |
Why?
| | Drug Information Services | 6 | 1988 | 9 | 0.220 |
Why?
| | Alcoholism | 5 | 2000 | 716 | 0.210 |
Why?
| | Free Radicals | 2 | 1993 | 99 | 0.210 |
Why?
| | Imines | 1 | 2022 | 7 | 0.210 |
Why?
| | Suicide, Attempted | 12 | 1990 | 314 | 0.200 |
Why?
| | Benzoquinones | 1 | 2022 | 44 | 0.200 |
Why?
| | Salicylates | 7 | 1989 | 30 | 0.200 |
Why?
| | Exchange Transfusion, Whole Blood | 2 | 1992 | 15 | 0.190 |
Why?
| | Ipecac | 6 | 1990 | 8 | 0.190 |
Why?
| | Thiosulfates | 4 | 1993 | 19 | 0.190 |
Why?
| | Time-to-Treatment | 2 | 2019 | 147 | 0.180 |
Why?
| | Liver Function Tests | 3 | 2012 | 106 | 0.180 |
Why?
| | Physostigmine | 6 | 1983 | 10 | 0.180 |
Why?
| | Acute Kidney Injury | 4 | 2020 | 638 | 0.180 |
Why?
| | Seizures | 6 | 1991 | 341 | 0.180 |
Why?
| | Coma | 9 | 1990 | 30 | 0.180 |
Why?
| | United States | 15 | 2012 | 12224 | 0.180 |
Why?
| | Hypotension | 5 | 1989 | 114 | 0.180 |
Why?
| | Cytochrome P-450 CYP2E1 Inhibitors | 1 | 2019 | 2 | 0.170 |
Why?
| | Emergencies | 6 | 1989 | 147 | 0.170 |
Why?
| | Ambulatory Care | 1 | 2023 | 478 | 0.170 |
Why?
| | Metabolome | 1 | 2022 | 285 | 0.170 |
Why?
| | Electric Power Supplies | 3 | 1992 | 48 | 0.170 |
Why?
| | Evidence-Based Medicine | 1 | 2023 | 676 | 0.160 |
Why?
| | Agaricales | 1 | 2018 | 3 | 0.160 |
Why?
| | Smoke Inhalation Injury | 2 | 1989 | 19 | 0.160 |
Why?
| | Fever | 2 | 2000 | 280 | 0.160 |
Why?
| | Emetics | 5 | 1984 | 7 | 0.160 |
Why?
| | Magnesium | 3 | 1988 | 145 | 0.160 |
Why?
| | Administration, Intravenous | 2 | 2016 | 125 | 0.150 |
Why?
| | Foreign Bodies | 3 | 1992 | 99 | 0.150 |
Why?
| | Drug Monitoring | 1 | 1999 | 184 | 0.150 |
Why?
| | Excipients | 2 | 1988 | 49 | 0.150 |
Why?
| | Histamine Antagonists | 1 | 2018 | 20 | 0.150 |
Why?
| | Middle Aged | 22 | 2023 | 26826 | 0.150 |
Why?
| | Sex Factors | 5 | 2022 | 1721 | 0.150 |
Why?
| | Cathartics | 4 | 1992 | 11 | 0.150 |
Why?
| | Glutathione | 5 | 2022 | 302 | 0.150 |
Why?
| | Information Systems | 4 | 2010 | 61 | 0.150 |
Why?
| | Dermatitis, Contact | 2 | 1989 | 23 | 0.150 |
Why?
| | Prothrombin Time | 3 | 1993 | 34 | 0.150 |
Why?
| | Phenytoin | 3 | 2004 | 13 | 0.140 |
Why?
| | Hospital Mortality | 1 | 2021 | 776 | 0.140 |
Why?
| | Occupational Diseases | 2 | 1990 | 128 | 0.140 |
Why?
| | Clinical Decision-Making | 1 | 2019 | 267 | 0.130 |
Why?
| | Hospitals | 1 | 2021 | 582 | 0.130 |
Why?
| | Drug Interactions | 4 | 2019 | 347 | 0.130 |
Why?
| | Amygdalin | 3 | 1986 | 3 | 0.130 |
Why?
| | Toxicology | 3 | 1990 | 36 | 0.130 |
Why?
| | Cimetidine | 1 | 1995 | 15 | 0.130 |
Why?
| | Patient Selection | 1 | 2019 | 646 | 0.120 |
Why?
| | Animals | 24 | 2023 | 31867 | 0.120 |
Why?
| | 3,4-Methylenedioxyamphetamine | 2 | 1987 | 2 | 0.120 |
Why?
| | Amphetamines | 2 | 1987 | 4 | 0.120 |
Why?
| | Arsenic Poisoning | 2 | 1989 | 7 | 0.120 |
Why?
| | Mice, Inbred C57BL | 5 | 2023 | 4718 | 0.120 |
Why?
| | Treatment Outcome | 3 | 2018 | 9122 | 0.120 |
Why?
| | Cohort Studies | 2 | 2018 | 4904 | 0.120 |
Why?
| | Drug Administration Schedule | 4 | 2014 | 719 | 0.120 |
Why?
| | Risk Factors | 4 | 2019 | 8642 | 0.120 |
Why?
| | Aspartate Aminotransferases | 6 | 2002 | 86 | 0.110 |
Why?
| | Predictive Value of Tests | 1 | 2019 | 1812 | 0.110 |
Why?
| | Riots | 1 | 1993 | 2 | 0.110 |
Why?
| | Psychophysiologic Disorders | 1 | 1993 | 10 | 0.110 |
Why?
| | Protein Kinase Inhibitors | 1 | 2019 | 786 | 0.110 |
Why?
| | Societies | 5 | 2012 | 37 | 0.110 |
Why?
| | Prospective Studies | 11 | 2020 | 6232 | 0.110 |
Why?
| | Acute Disease | 8 | 1993 | 915 | 0.110 |
Why?
| | Risk | 5 | 2009 | 815 | 0.110 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2551 | 0.110 |
Why?
| | Carbon Tetrachloride | 1 | 1993 | 6 | 0.110 |
Why?
| | Hydrocarbons, Halogenated | 1 | 1993 | 5 | 0.110 |
Why?
| | Methemoglobin | 3 | 1989 | 19 | 0.110 |
Why?
| | Prognosis | 3 | 2019 | 3334 | 0.110 |
Why?
| | Xenobiotics | 1 | 2012 | 24 | 0.100 |
Why?
| | Phenobarbital | 4 | 2004 | 17 | 0.100 |
Why?
| | United States Food and Drug Administration | 2 | 2012 | 172 | 0.100 |
Why?
| | Electrolytes | 2 | 1990 | 55 | 0.100 |
Why?
| | Warfarin | 1 | 1993 | 135 | 0.100 |
Why?
| | Life Change Events | 1 | 1993 | 135 | 0.100 |
Why?
| | Genetic Predisposition to Disease | 1 | 2020 | 2108 | 0.100 |
Why?
| | Digestive System | 1 | 1992 | 27 | 0.100 |
Why?
| | Hydrocarbons | 2 | 1986 | 29 | 0.100 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1715 | 0.100 |
Why?
| | Drug Dosage Calculations | 1 | 2012 | 21 | 0.100 |
Why?
| | Vascular Headaches | 1 | 1991 | 1 | 0.100 |
Why?
| | Fluoride Poisoning | 1 | 1991 | 4 | 0.100 |
Why?
| | Bromocriptine | 1 | 1991 | 26 | 0.100 |
Why?
| | Carbon Tetrachloride Poisoning | 1 | 1991 | 2 | 0.100 |
Why?
| | Sympathomimetics | 1 | 1991 | 25 | 0.100 |
Why?
| | Incidence | 1 | 2018 | 2318 | 0.100 |
Why?
| | Gas Poisoning | 2 | 1993 | 4 | 0.100 |
Why?
| | Magnesium Sulfate | 2 | 1988 | 17 | 0.100 |
Why?
| | Methanol | 1 | 1991 | 29 | 0.090 |
Why?
| | Hydroxocobalamin | 2 | 1993 | 26 | 0.090 |
Why?
| | Methemoglobinemia | 3 | 1986 | 13 | 0.090 |
Why?
| | Vancomycin | 1 | 1992 | 75 | 0.090 |
Why?
| | Information Services | 3 | 1990 | 45 | 0.090 |
Why?
| | Gastric Lavage | 6 | 1992 | 9 | 0.090 |
Why?
| | Substance-Related Disorders | 4 | 1987 | 945 | 0.090 |
Why?
| | Pregnancy Complications | 2 | 1989 | 430 | 0.090 |
Why?
| | Therapeutic Irrigation | 1 | 1990 | 67 | 0.090 |
Why?
| | Sulfates | 1 | 1990 | 43 | 0.090 |
Why?
| | Pyridoxine | 1 | 1990 | 28 | 0.090 |
Why?
| | Liver Diseases | 4 | 2002 | 259 | 0.090 |
Why?
| | Naloxone | 4 | 1985 | 97 | 0.090 |
Why?
| | Alcoholic Intoxication | 2 | 1988 | 62 | 0.090 |
Why?
| | Hospitalization | 2 | 2019 | 1754 | 0.090 |
Why?
| | Amphotericin B | 1 | 1990 | 30 | 0.090 |
Why?
| | Interior Design and Furnishings | 1 | 1990 | 4 | 0.090 |
Why?
| | Isoniazid | 1 | 1990 | 52 | 0.090 |
Why?
| | Methylene Chloride | 1 | 1990 | 4 | 0.090 |
Why?
| | Hydrofluoric Acid | 2 | 1989 | 8 | 0.090 |
Why?
| | Facility Design and Construction | 1 | 1990 | 11 | 0.090 |
Why?
| | Societies, Scientific | 1 | 1990 | 47 | 0.090 |
Why?
| | Hydrocarbons, Chlorinated | 1 | 1990 | 20 | 0.090 |
Why?
| | Phenelzine | 2 | 1987 | 4 | 0.090 |
Why?
| | Rodenticides | 1 | 1989 | 4 | 0.090 |
Why?
| | 4-Hydroxycoumarins | 1 | 1989 | 4 | 0.090 |
Why?
| | Kinetics | 12 | 1987 | 1558 | 0.090 |
Why?
| | Mycoses | 1 | 1990 | 66 | 0.080 |
Why?
| | Penicillamine | 5 | 1986 | 22 | 0.080 |
Why?
| | Plants, Toxic | 2 | 1987 | 23 | 0.080 |
Why?
| | Iron | 1 | 1991 | 234 | 0.080 |
Why?
| | Half-Life | 7 | 1992 | 143 | 0.080 |
Why?
| | Sodium Compounds | 1 | 1989 | 3 | 0.080 |
Why?
| | Arsenites | 1 | 1989 | 4 | 0.080 |
Why?
| | Eucalyptus | 1 | 1989 | 5 | 0.080 |
Why?
| | Plant Oils | 1 | 1989 | 27 | 0.080 |
Why?
| | Reproducibility of Results | 1 | 2016 | 2799 | 0.080 |
Why?
| | Thyroxine | 2 | 1987 | 58 | 0.080 |
Why?
| | Chlorambucil | 1 | 1988 | 8 | 0.080 |
Why?
| | Trees | 1 | 1989 | 62 | 0.080 |
Why?
| | Writing | 1 | 1990 | 85 | 0.080 |
Why?
| | Construction Materials | 2 | 1986 | 13 | 0.080 |
Why?
| | Antioxidants | 2 | 1993 | 530 | 0.080 |
Why?
| | Alprazolam | 1 | 1988 | 6 | 0.080 |
Why?
| | Perfume | 1 | 1988 | 3 | 0.080 |
Why?
| | Captopril | 1 | 1988 | 11 | 0.080 |
Why?
| | Botany | 1 | 1988 | 2 | 0.080 |
Why?
| | Critical Pathways | 1 | 2009 | 74 | 0.080 |
Why?
| | Adverse Drug Reaction Reporting Systems | 1 | 2008 | 68 | 0.080 |
Why?
| | Vomiting | 3 | 1988 | 124 | 0.080 |
Why?
| | Heart Diseases | 1 | 1991 | 330 | 0.080 |
Why?
| | Aged | 8 | 2020 | 19119 | 0.080 |
Why?
| | Polyethylene Glycols | 2 | 1990 | 561 | 0.080 |
Why?
| | Chewing Gum | 1 | 1988 | 8 | 0.080 |
Why?
| | Fabaceae | 1 | 1988 | 7 | 0.080 |
Why?
| | Sweetening Agents | 1 | 1988 | 37 | 0.080 |
Why?
| | Diflunisal | 1 | 1987 | 2 | 0.080 |
Why?
| | Zinc | 1 | 1990 | 256 | 0.070 |
Why?
| | Intestinal Absorption | 3 | 1999 | 93 | 0.070 |
Why?
| | Imipramine | 3 | 1979 | 12 | 0.070 |
Why?
| | Arrhythmias, Cardiac | 3 | 1981 | 278 | 0.070 |
Why?
| | Theophylline | 1 | 1987 | 60 | 0.070 |
Why?
| | Fruit | 1 | 1988 | 127 | 0.070 |
Why?
| | Medication Systems | 1 | 1987 | 2 | 0.070 |
Why?
| | International System of Units | 1 | 1987 | 2 | 0.070 |
Why?
| | Weights and Measures | 1 | 1987 | 7 | 0.070 |
Why?
| | Basidiomycota | 1 | 1987 | 22 | 0.070 |
Why?
| | Drug Therapy, Combination | 3 | 2002 | 955 | 0.070 |
Why?
| | Quinine | 1 | 1987 | 11 | 0.070 |
Why?
| | Pharmacy Service, Hospital | 1 | 1988 | 84 | 0.070 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2012 | 1214 | 0.070 |
Why?
| | Blood Coagulation Disorders | 1 | 1989 | 195 | 0.070 |
Why?
| | Mistletoe | 1 | 1986 | 1 | 0.070 |
Why?
| | Antidepressive Agents, Tricyclic | 1 | 1987 | 29 | 0.070 |
Why?
| | Blindness | 1 | 1987 | 37 | 0.070 |
Why?
| | Population Surveillance | 4 | 2011 | 392 | 0.070 |
Why?
| | Clonidine | 2 | 1983 | 26 | 0.070 |
Why?
| | Xylazine | 1 | 1986 | 6 | 0.070 |
Why?
| | Thiazines | 1 | 1986 | 9 | 0.070 |
Why?
| | Microsomes, Liver | 4 | 1976 | 56 | 0.070 |
Why?
| | Magnesium Compounds | 1 | 1986 | 2 | 0.070 |
Why?
| | Aluminum Compounds | 1 | 1986 | 6 | 0.070 |
Why?
| | Silicates | 1 | 1986 | 11 | 0.070 |
Why?
| | Boric Acids | 1 | 1986 | 1 | 0.070 |
Why?
| | Atropine | 4 | 1987 | 31 | 0.070 |
Why?
| | Oxidoreductases | 3 | 1986 | 92 | 0.070 |
Why?
| | Yohimbine | 1 | 1985 | 11 | 0.070 |
Why?
| | Kidney | 3 | 2023 | 1186 | 0.060 |
Why?
| | Mice | 4 | 2023 | 14927 | 0.060 |
Why?
| | Epinephrine | 1 | 1987 | 167 | 0.060 |
Why?
| | Guanabenz | 1 | 1985 | 1 | 0.060 |
Why?
| | Infant, Newborn | 7 | 2008 | 5040 | 0.060 |
Why?
| | Guanidines | 1 | 1985 | 33 | 0.060 |
Why?
| | Amitriptyline | 3 | 1983 | 21 | 0.060 |
Why?
| | Pancreatitis | 1 | 1986 | 107 | 0.060 |
Why?
| | Accidents, Home | 5 | 1988 | 27 | 0.060 |
Why?
| | Nicotine | 1 | 1988 | 266 | 0.060 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 1993 | 757 | 0.060 |
Why?
| | Gastric Emptying | 1 | 1985 | 40 | 0.060 |
Why?
| | Substance Withdrawal Syndrome | 3 | 1985 | 159 | 0.060 |
Why?
| | Chlorobenzenes | 1 | 1985 | 8 | 0.060 |
Why?
| | Injections, Intravenous | 4 | 1991 | 202 | 0.060 |
Why?
| | Marine Toxins | 1 | 1985 | 12 | 0.060 |
Why?
| | Bronchodilator Agents | 1 | 1987 | 243 | 0.060 |
Why?
| | Naphthalenes | 1 | 1985 | 38 | 0.060 |
Why?
| | Insecticides | 1 | 1985 | 31 | 0.060 |
Why?
| | Morphinans | 3 | 1973 | 7 | 0.060 |
Why?
| | Computers | 2 | 1988 | 60 | 0.060 |
Why?
| | Lactones | 1 | 1985 | 54 | 0.060 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2014 | 1857 | 0.060 |
Why?
| | Bacterial Toxins | 1 | 1985 | 103 | 0.060 |
Why?
| | Heroin | 1 | 1984 | 23 | 0.060 |
Why?
| | Cyanobacteria | 1 | 1985 | 54 | 0.060 |
Why?
| | Medical History Taking | 2 | 1999 | 115 | 0.060 |
Why?
| | Deglutition | 1 | 1984 | 58 | 0.060 |
Why?
| | Oxidation-Reduction | 2 | 2019 | 926 | 0.050 |
Why?
| | Cognition Disorders | 1 | 1987 | 475 | 0.050 |
Why?
| | Household Products | 1 | 1983 | 6 | 0.050 |
Why?
| | Ethylene Glycols | 1 | 1983 | 14 | 0.050 |
Why?
| | Copper | 1 | 1984 | 99 | 0.050 |
Why?
| | Online Systems | 1 | 1983 | 23 | 0.050 |
Why?
| | Talc | 1 | 1982 | 5 | 0.050 |
Why?
| | Drug Labeling | 2 | 2000 | 42 | 0.050 |
Why?
| | Barbiturates | 2 | 2002 | 4 | 0.050 |
Why?
| | Infant Care | 1 | 1982 | 42 | 0.050 |
Why?
| | Hallucinations | 4 | 1979 | 29 | 0.050 |
Why?
| | Lactates | 1 | 2022 | 84 | 0.050 |
Why?
| | Hemorrhage | 1 | 1986 | 618 | 0.050 |
Why?
| | Phenylurea Compounds | 1 | 2022 | 82 | 0.050 |
Why?
| | Pharmaceutical Preparations | 1 | 1984 | 169 | 0.050 |
Why?
| | Enzyme Induction | 1 | 2002 | 84 | 0.050 |
Why?
| | Phenylpropanolamine | 3 | 1982 | 3 | 0.050 |
Why?
| | Transaminases | 2 | 2014 | 25 | 0.050 |
Why?
| | Nutritional Physiological Phenomena | 1 | 2002 | 48 | 0.050 |
Why?
| | Cross-Sectional Studies | 1 | 2012 | 4411 | 0.050 |
Why?
| | Colorado | 7 | 1992 | 4089 | 0.050 |
Why?
| | Phencyclidine Abuse | 1 | 1980 | 1 | 0.050 |
Why?
| | Stomach | 4 | 1988 | 101 | 0.050 |
Why?
| | Fluid Therapy | 3 | 1988 | 121 | 0.050 |
Why?
| | Pharmacology | 1 | 2000 | 8 | 0.040 |
Why?
| | Activation, Metabolic | 1 | 2019 | 4 | 0.040 |
Why?
| | Anticonvulsants | 1 | 2002 | 178 | 0.040 |
Why?
| | Clinical Trials as Topic | 2 | 2000 | 937 | 0.040 |
Why?
| | Methapyrilene | 1 | 1979 | 1 | 0.040 |
Why?
| | Salicylamides | 1 | 1979 | 3 | 0.040 |
Why?
| | Immune System | 1 | 2020 | 172 | 0.040 |
Why?
| | Pediatrics | 1 | 1987 | 981 | 0.040 |
Why?
| | Psychology, Child | 1 | 1979 | 37 | 0.040 |
Why?
| | Drug Compounding | 1 | 1999 | 89 | 0.040 |
Why?
| | Molecular Docking Simulation | 1 | 2019 | 102 | 0.040 |
Why?
| | Age Factors | 4 | 1999 | 2894 | 0.040 |
Why?
| | Critical Care | 1 | 1983 | 475 | 0.040 |
Why?
| | Digoxin | 2 | 1979 | 26 | 0.040 |
Why?
| | Lipids | 1 | 2022 | 586 | 0.040 |
Why?
| | Aminopyridines | 1 | 1979 | 81 | 0.040 |
Why?
| | Evaluation Studies as Topic | 4 | 1988 | 169 | 0.040 |
Why?
| | Mitochondria | 1 | 2023 | 750 | 0.040 |
Why?
| | Cross-Over Studies | 1 | 2019 | 441 | 0.040 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 1986 | 1353 | 0.040 |
Why?
| | Heart Arrest | 1 | 1981 | 289 | 0.040 |
Why?
| | Infant, Newborn, Diseases | 2 | 1981 | 104 | 0.040 |
Why?
| | Caustics | 1 | 1977 | 7 | 0.040 |
Why?
| | Child Behavior | 1 | 1979 | 219 | 0.040 |
Why?
| | Metabolic Clearance Rate | 2 | 1987 | 106 | 0.030 |
Why?
| | Hypertension | 4 | 1987 | 1058 | 0.030 |
Why?
| | Protein Binding | 3 | 2019 | 1898 | 0.030 |
Why?
| | Fatal Outcome | 1 | 1997 | 285 | 0.030 |
Why?
| | Calcium Gluconate | 2 | 1989 | 4 | 0.030 |
Why?
| | Pilot Projects | 1 | 2020 | 1375 | 0.030 |
Why?
| | Heart Rate | 3 | 1993 | 705 | 0.030 |
Why?
| | Glutethimide | 2 | 1979 | 2 | 0.030 |
Why?
| | Kidney Diseases | 2 | 1992 | 350 | 0.030 |
Why?
| | Genetic Variation | 1 | 2020 | 876 | 0.030 |
Why?
| | Ethchlorvynol | 2 | 1979 | 2 | 0.030 |
Why?
| | Central Nervous System | 3 | 1986 | 238 | 0.030 |
Why?
| | Apoptosis | 1 | 2023 | 2366 | 0.030 |
Why?
| | Isonipecotic Acids | 1 | 1974 | 1 | 0.030 |
Why?
| | Dopamine | 2 | 1988 | 235 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2021 | 2191 | 0.030 |
Why?
| | Chemistry | 4 | 1985 | 39 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2020 | 1203 | 0.030 |
Why?
| | Clomipramine | 1 | 1974 | 2 | 0.030 |
Why?
| | Dibenzazepines | 1 | 1974 | 4 | 0.030 |
Why?
| | Central Nervous System Diseases | 2 | 1987 | 61 | 0.030 |
Why?
| | Chemical Phenomena | 4 | 1985 | 81 | 0.030 |
Why?
| | Protein Deficiency | 1 | 1973 | 3 | 0.030 |
Why?
| | Quaternary Ammonium Compounds | 1 | 1974 | 44 | 0.030 |
Why?
| | Parasympatholytics | 1 | 1973 | 13 | 0.030 |
Why?
| | Georgia (Republic) | 1 | 1993 | 2 | 0.030 |
Why?
| | Civil Rights | 1 | 1993 | 9 | 0.030 |
Why?
| | Gastrointestinal Agents | 1 | 1974 | 60 | 0.030 |
Why?
| | Oxidoreductases, N-Demethylating | 1 | 1973 | 10 | 0.030 |
Why?
| | Conversion Disorder | 1 | 1993 | 9 | 0.030 |
Why?
| | Pregnancy | 6 | 1989 | 5519 | 0.030 |
Why?
| | Diquat | 1 | 1993 | 1 | 0.030 |
Why?
| | Animals, Domestic | 1 | 2012 | 11 | 0.030 |
Why?
| | Amoxapine | 2 | 1982 | 2 | 0.030 |
Why?
| | Dibenzoxazepines | 2 | 1982 | 2 | 0.030 |
Why?
| | Mercury Poisoning | 2 | 1983 | 6 | 0.030 |
Why?
| | Drug Combinations | 4 | 1993 | 287 | 0.030 |
Why?
| | Injections, Intramuscular | 2 | 1986 | 118 | 0.030 |
Why?
| | Dietary Proteins | 1 | 1973 | 123 | 0.030 |
Why?
| | Treatment Failure | 1 | 1993 | 332 | 0.030 |
Why?
| | Fluorides, Topical | 1 | 1991 | 13 | 0.020 |
Why?
| | Ear Diseases | 1 | 1992 | 13 | 0.020 |
Why?
| | Electrocardiography | 4 | 1983 | 562 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 1982 | 1811 | 0.020 |
Why?
| | Accidents | 1 | 1991 | 38 | 0.020 |
Why?
| | Algorithms | 1 | 2018 | 1488 | 0.020 |
Why?
| | Transferrin | 1 | 1991 | 40 | 0.020 |
Why?
| | Lactoferrin | 1 | 1991 | 28 | 0.020 |
Why?
| | Bicarbonates | 1 | 1991 | 41 | 0.020 |
Why?
| | Psychiatric Status Rating Scales | 1 | 1993 | 484 | 0.020 |
Why?
| | Ferritins | 1 | 1991 | 52 | 0.020 |
Why?
| | Biomarkers | 1 | 2021 | 3419 | 0.020 |
Why?
| | Hemoperfusion | 3 | 1979 | 4 | 0.020 |
Why?
| | Administration, Rectal | 1 | 1990 | 5 | 0.020 |
Why?
| | Zinc Sulfate | 1 | 1990 | 8 | 0.020 |
Why?
| | Anticoagulants | 2 | 1989 | 546 | 0.020 |
Why?
| | Physicians | 2 | 1993 | 771 | 0.020 |
Why?
| | Urography | 1 | 1990 | 13 | 0.020 |
Why?
| | Lactation | 1 | 1991 | 149 | 0.020 |
Why?
| | Disease Outbreaks | 1 | 1993 | 309 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2018 | 3896 | 0.020 |
Why?
| | Creatinine | 1 | 1992 | 425 | 0.020 |
Why?
| | Dimercaprol | 2 | 1981 | 6 | 0.020 |
Why?
| | Skin | 4 | 1989 | 659 | 0.020 |
Why?
| | Protective Devices | 1 | 1990 | 26 | 0.020 |
Why?
| | Amyl Nitrite | 1 | 1989 | 1 | 0.020 |
Why?
| | Ventilators, Mechanical | 1 | 1990 | 52 | 0.020 |
Why?
| | Fetal Death | 1 | 1989 | 50 | 0.020 |
Why?
| | Therapeutic Equivalency | 1 | 1989 | 18 | 0.020 |
Why?
| | Carboxyhemoglobin | 1 | 1989 | 5 | 0.020 |
Why?
| | Apnea | 2 | 1986 | 17 | 0.020 |
Why?
| | Physician-Patient Relations | 1 | 1993 | 463 | 0.020 |
Why?
| | Arsenic | 1 | 1989 | 37 | 0.020 |
Why?
| | Cytochrome-B(5) Reductase | 2 | 1986 | 2 | 0.020 |
Why?
| | Abortion, Spontaneous | 1 | 1989 | 91 | 0.020 |
Why?
| | Survival Rate | 1 | 2012 | 1646 | 0.020 |
Why?
| | Congresses as Topic | 1 | 1990 | 198 | 0.020 |
Why?
| | Acidosis | 1 | 1989 | 87 | 0.020 |
Why?
| | Tablets | 1 | 1988 | 36 | 0.020 |
Why?
| | Dogs | 2 | 1987 | 340 | 0.020 |
Why?
| | Information Centers | 1 | 1988 | 4 | 0.020 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 1989 | 102 | 0.020 |
Why?
| | Tobacco, Smokeless | 1 | 1988 | 9 | 0.020 |
Why?
| | Peripheral Nervous System Diseases | 1 | 1989 | 120 | 0.020 |
Why?
| | Salicylic Acid | 1 | 1987 | 8 | 0.020 |
Why?
| | Thirst | 1 | 1987 | 5 | 0.020 |
Why?
| | Pulse | 1 | 1987 | 27 | 0.020 |
Why?
| | Bile | 1 | 1987 | 26 | 0.020 |
Why?
| | Saponins | 1 | 1987 | 6 | 0.020 |
Why?
| | Diagnosis, Differential | 2 | 1987 | 1355 | 0.020 |
Why?
| | Infant, Premature | 2 | 1981 | 477 | 0.020 |
Why?
| | Maternal-Fetal Exchange | 2 | 1981 | 151 | 0.020 |
Why?
| | Cysteamine | 2 | 1978 | 5 | 0.020 |
Why?
| | N-Methyl-3,4-methylenedioxyamphetamine | 1 | 1987 | 10 | 0.020 |
Why?
| | Carrier Proteins | 1 | 1991 | 696 | 0.020 |
Why?
| | Rats | 5 | 1983 | 4973 | 0.020 |
Why?
| | Keratoconjunctivitis | 1 | 1986 | 3 | 0.020 |
Why?
| | Arousal | 1 | 1987 | 151 | 0.020 |
Why?
| | Mortality | 1 | 1988 | 287 | 0.020 |
Why?
| | Lighting | 1 | 1986 | 25 | 0.020 |
Why?
| | Hemoglobin M | 1 | 1986 | 2 | 0.020 |
Why?
| | Electroencephalography | 1 | 1988 | 362 | 0.020 |
Why?
| | Abdomen, Acute | 1 | 1986 | 18 | 0.020 |
Why?
| | Inactivation, Metabolic | 1 | 1986 | 11 | 0.020 |
Why?
| | Methylene Blue | 1 | 1986 | 22 | 0.020 |
Why?
| | NADPH-Ferrihemoprotein Reductase | 1 | 1986 | 10 | 0.020 |
Why?
| | Ditiocarb | 1 | 1986 | 3 | 0.020 |
Why?
| | Ferrocyanides | 1 | 1986 | 4 | 0.020 |
Why?
| | Aminopropionitrile | 1 | 1986 | 2 | 0.020 |
Why?
| | Kaolin | 1 | 1986 | 5 | 0.020 |
Why?
| | Glycerides | 1 | 1986 | 15 | 0.020 |
Why?
| | Respiratory Tract Diseases | 1 | 1987 | 140 | 0.020 |
Why?
| | Aluminum Silicates | 1 | 1986 | 11 | 0.020 |
Why?
| | Drug Synergism | 1 | 1987 | 317 | 0.020 |
Why?
| | Documentation | 1 | 1988 | 169 | 0.020 |
Why?
| | Thioctic Acid | 1 | 1986 | 10 | 0.020 |
Why?
| | Carmustine | 1 | 1986 | 47 | 0.020 |
Why?
| | Polychlorinated Dibenzodioxins | 1 | 1985 | 5 | 0.020 |
Why?
| | Dioxins | 1 | 1985 | 4 | 0.020 |
Why?
| | Intubation, Gastrointestinal | 1 | 1986 | 53 | 0.020 |
Why?
| | Gastrointestinal Diseases | 1 | 1987 | 182 | 0.020 |
Why?
| | Latex | 1 | 1985 | 9 | 0.020 |
Why?
| | Triiodothyronine | 1 | 1985 | 42 | 0.020 |
Why?
| | Propylene Glycols | 1 | 1985 | 25 | 0.020 |
Why?
| | Niacinamide | 1 | 1986 | 62 | 0.020 |
Why?
| | Smoking | 1 | 1993 | 1392 | 0.020 |
Why?
| | Antivenins | 1 | 1986 | 56 | 0.020 |
Why?
| | Chromatography, High Pressure Liquid | 3 | 1993 | 474 | 0.020 |
Why?
| | Respiration | 1 | 1986 | 182 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 1988 | 1127 | 0.020 |
Why?
| | Irritants | 1 | 1985 | 41 | 0.020 |
Why?
| | Turpentine | 1 | 1985 | 5 | 0.020 |
Why?
| | Fluorouracil | 1 | 1986 | 152 | 0.020 |
Why?
| | Sleep Stages | 1 | 1985 | 61 | 0.020 |
Why?
| | Ivermectin | 1 | 1985 | 9 | 0.020 |
Why?
| | Microcystins | 1 | 1985 | 7 | 0.020 |
Why?
| | Brucella | 1 | 1964 | 1 | 0.020 |
Why?
| | Spheroplasts | 1 | 1964 | 2 | 0.020 |
Why?
| | Data Collection | 1 | 1988 | 623 | 0.020 |
Why?
| | Cytochrome P-450 Enzyme System | 3 | 1976 | 108 | 0.020 |
Why?
| | Intestines | 1 | 1988 | 322 | 0.020 |
Why?
| | Oxygen Inhalation Therapy | 1 | 1986 | 129 | 0.020 |
Why?
| | Biochemical Phenomena | 1 | 1964 | 10 | 0.020 |
Why?
| | Bradycardia | 1 | 1985 | 48 | 0.020 |
Why?
| | Tachycardia | 2 | 1987 | 50 | 0.020 |
Why?
| | Blood Pressure | 2 | 1993 | 1539 | 0.010 |
Why?
| | Arginine | 1 | 1986 | 238 | 0.010 |
Why?
| | Penicillins | 1 | 1964 | 52 | 0.010 |
Why?
| | Doxorubicin | 1 | 1986 | 285 | 0.010 |
Why?
| | Tissue Culture Techniques | 1 | 1964 | 66 | 0.010 |
Why?
| | Culture Media | 1 | 1964 | 155 | 0.010 |
Why?
| | Solvents | 1 | 1985 | 104 | 0.010 |
Why?
| | Random Allocation | 1 | 1985 | 336 | 0.010 |
Why?
| | Biochemistry | 1 | 1964 | 40 | 0.010 |
Why?
| | Solubility | 1 | 1985 | 224 | 0.010 |
Why?
| | Burns, Chemical | 2 | 1981 | 25 | 0.010 |
Why?
| | Homeostasis | 1 | 1988 | 578 | 0.010 |
Why?
| | Copper Sulfate | 1 | 1984 | 6 | 0.010 |
Why?
| | Chlorpheniramine | 2 | 1974 | 9 | 0.010 |
Why?
| | Biotransformation | 1 | 1984 | 50 | 0.010 |
Why?
| | Cytoplasm | 1 | 1964 | 256 | 0.010 |
Why?
| | Glycine | 1 | 1964 | 153 | 0.010 |
Why?
| | Infusions, Parenteral | 1 | 1983 | 37 | 0.010 |
Why?
| | Ultraviolet Rays | 1 | 1986 | 368 | 0.010 |
Why?
| | Drug Packaging | 1 | 1984 | 43 | 0.010 |
Why?
| | Radiography | 2 | 1983 | 827 | 0.010 |
Why?
| | Endotoxins | 1 | 1964 | 205 | 0.010 |
Why?
| | Bilirubin | 1 | 1984 | 88 | 0.010 |
Why?
| | Mercury Compounds | 1 | 1983 | 3 | 0.010 |
Why?
| | Diuresis | 2 | 1980 | 8 | 0.010 |
Why?
| | Bacteriophages | 1 | 1964 | 75 | 0.010 |
Why?
| | Foreign-Body Reaction | 1 | 1983 | 22 | 0.010 |
Why?
| | Dextropropoxyphene | 2 | 1980 | 3 | 0.010 |
Why?
| | Mercury | 1 | 1983 | 28 | 0.010 |
Why?
| | Enema | 1 | 1983 | 38 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 1992 | 4420 | 0.010 |
Why?
| | Ephedrine | 1 | 1982 | 4 | 0.010 |
Why?
| | Oxides | 1 | 1983 | 43 | 0.010 |
Why?
| | Cysteine | 1 | 1984 | 171 | 0.010 |
Why?
| | Cytochromes | 2 | 1973 | 9 | 0.010 |
Why?
| | History, 20th Century | 1 | 1984 | 267 | 0.010 |
Why?
| | Powders | 1 | 1982 | 38 | 0.010 |
Why?
| | Inhalation | 1 | 1982 | 26 | 0.010 |
Why?
| | Phagocytosis | 1 | 1964 | 352 | 0.010 |
Why?
| | Seasons | 1 | 1985 | 448 | 0.010 |
Why?
| | Gagging | 1 | 1982 | 1 | 0.010 |
Why?
| | Caffeine | 1 | 1982 | 57 | 0.010 |
Why?
| | Blood Glucose | 1 | 1991 | 1821 | 0.010 |
Why?
| | Cattle | 1 | 1985 | 924 | 0.010 |
Why?
| | Consciousness | 1 | 1982 | 20 | 0.010 |
Why?
| | Diarrhea | 1 | 1983 | 171 | 0.010 |
Why?
| | Lethal Dose 50 | 1 | 1981 | 12 | 0.010 |
Why?
| | Reflex | 1 | 1982 | 65 | 0.010 |
Why?
| | Gluconates | 1 | 1981 | 4 | 0.010 |
Why?
| | Monocytes | 1 | 1964 | 503 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2012 | 6357 | 0.010 |
Why?
| | Down Syndrome | 1 | 1986 | 335 | 0.010 |
Why?
| | Carbamazepine | 1 | 1981 | 18 | 0.010 |
Why?
| | Research | 1 | 1964 | 395 | 0.010 |
Why?
| | Drug Evaluation | 1 | 1981 | 77 | 0.010 |
Why?
| | Esophagus | 1 | 1983 | 226 | 0.010 |
Why?
| | Formaldehyde | 1 | 1981 | 46 | 0.010 |
Why?
| | Cerebral Hemorrhage | 1 | 1981 | 96 | 0.010 |
Why?
| | Selenium | 1 | 1981 | 31 | 0.010 |
Why?
| | Microchemistry | 2 | 1978 | 15 | 0.010 |
Why?
| | Polyurethanes | 1 | 1981 | 34 | 0.010 |
Why?
| | Nurses | 1 | 1983 | 144 | 0.010 |
Why?
| | Gold | 1 | 1981 | 106 | 0.010 |
Why?
| | Urea | 1 | 1981 | 68 | 0.010 |
Why?
| | Furosemide | 1 | 1980 | 32 | 0.010 |
Why?
| | Enzyme Activation | 2 | 1973 | 791 | 0.010 |
Why?
| | Pharmacists | 1 | 1983 | 236 | 0.010 |
Why?
| | Pharmacokinetics | 1 | 2000 | 25 | 0.010 |
Why?
| | Methods | 2 | 1977 | 59 | 0.010 |
Why?
| | Cyclohexanones | 1 | 1979 | 8 | 0.010 |
Why?
| | Oils, Volatile | 1 | 1979 | 6 | 0.010 |
Why?
| | Calcium | 1 | 1986 | 1104 | 0.010 |
Why?
| | Metabolism | 1 | 2000 | 35 | 0.010 |
Why?
| | Interprofessional Relations | 1 | 1982 | 251 | 0.010 |
Why?
| | Abortifacient Agents | 1 | 1979 | 5 | 0.010 |
Why?
| | Cyclohexanes | 1 | 1979 | 22 | 0.010 |
Why?
| | Phenothiazines | 1 | 1979 | 7 | 0.010 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 1979 | 30 | 0.010 |
Why?
| | Housing | 1 | 1981 | 114 | 0.010 |
Why?
| | Nitrates | 1 | 1979 | 72 | 0.010 |
Why?
| | Emergency Medical Services | 1 | 1987 | 587 | 0.010 |
Why?
| | Enuresis | 1 | 1979 | 3 | 0.010 |
Why?
| | Arthritis, Juvenile | 1 | 1979 | 42 | 0.010 |
Why?
| | Hemostasis | 1 | 1979 | 67 | 0.010 |
Why?
| | Microfilming | 1 | 1979 | 1 | 0.010 |
Why?
| | Self Medication | 1 | 1979 | 9 | 0.010 |
Why?
| | Gingival Neoplasms | 1 | 1979 | 10 | 0.010 |
Why?
| | Thiocyanates | 1 | 1979 | 29 | 0.010 |
Why?
| | Valproic Acid | 1 | 1979 | 43 | 0.010 |
Why?
| | Necrosis | 2 | 1979 | 210 | 0.010 |
Why?
| | Opioid-Related Disorders | 1 | 1985 | 414 | 0.010 |
Why?
| | Software | 1 | 1983 | 537 | 0.010 |
Why?
| | Podophyllin | 1 | 1978 | 1 | 0.010 |
Why?
| | Pregnancy Trimester, Third | 1 | 1979 | 78 | 0.010 |
Why?
| | Alkaloids | 1 | 1978 | 22 | 0.010 |
Why?
| | Mitral Valve | 1 | 1979 | 86 | 0.010 |
Why?
| | Skin Manifestations | 2 | 1975 | 2 | 0.010 |
Why?
| | Magnoliopsida | 1 | 1978 | 28 | 0.010 |
Why?
| | Regional Health Planning | 1 | 1978 | 7 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 1987 | 3545 | 0.010 |
Why?
| | Beverages | 1 | 1978 | 60 | 0.010 |
Why?
| | Methionine | 1 | 1978 | 145 | 0.010 |
Why?
| | Transportation of Patients | 1 | 1978 | 52 | 0.010 |
Why?
| | Heart Valve Prosthesis | 1 | 1979 | 121 | 0.010 |
Why?
| | Spectrophotometry | 2 | 1976 | 48 | 0.010 |
Why?
| | Spectrophotometry, Ultraviolet | 2 | 1976 | 74 | 0.010 |
Why?
| | Clonazepam | 1 | 1977 | 4 | 0.010 |
Why?
| | Citrus | 1 | 1977 | 4 | 0.010 |
Why?
| | Benzodiazepinones | 1 | 1977 | 14 | 0.010 |
Why?
| | Fetal Blood | 1 | 1979 | 270 | 0.010 |
Why?
| | Oils | 1 | 1976 | 19 | 0.010 |
Why?
| | Acetates | 1 | 1977 | 95 | 0.010 |
Why?
| | Models, Chemical | 3 | 1985 | 250 | 0.010 |
Why?
| | Hypersensitivity | 1 | 1979 | 256 | 0.010 |
Why?
| | Patient Compliance | 1 | 2000 | 524 | 0.010 |
Why?
| | Milk | 1 | 1977 | 124 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 1987 | 4631 | 0.010 |
Why?
| | Kidney Papillary Necrosis | 1 | 1975 | 1 | 0.010 |
Why?
| | Pericarditis | 1 | 1975 | 9 | 0.010 |
Why?
| | Cardiovascular Diseases | 1 | 1987 | 1729 | 0.010 |
Why?
| | Agranulocytosis | 1 | 1975 | 31 | 0.010 |
Why?
| | Myoclonus | 1 | 1974 | 12 | 0.010 |
Why?
| | Athetosis | 1 | 1974 | 7 | 0.010 |
Why?
| | Chorea | 1 | 1974 | 11 | 0.010 |
Why?
| | Health Education | 1 | 1978 | 323 | 0.010 |
Why?
| | Levallorphan | 1 | 1974 | 1 | 0.010 |
Why?
| | Nalorphine | 1 | 1974 | 1 | 0.010 |
Why?
| | Temperature | 1 | 1977 | 578 | 0.010 |
Why?
| | Heart Block | 1 | 1974 | 38 | 0.010 |
Why?
| | Nitrosourea Compounds | 1 | 1973 | 1 | 0.010 |
Why?
| | Binding Sites | 2 | 1976 | 1173 | 0.010 |
Why?
| | Cytochrome Reductases | 1 | 1973 | 3 | 0.010 |
Why?
| | Hyperkalemia | 1 | 1974 | 26 | 0.010 |
Why?
| | Riboflavin | 1 | 1973 | 7 | 0.010 |
Why?
| | Flavin Mononucleotide | 1 | 1973 | 7 | 0.010 |
Why?
| | Histamine H1 Antagonists | 1 | 1973 | 33 | 0.010 |
Why?
| | Flavin-Adenine Dinucleotide | 1 | 1973 | 14 | 0.010 |
Why?
| | Macaca | 1 | 1973 | 50 | 0.010 |
Why?
| | Potassium | 1 | 1974 | 128 | 0.010 |
Why?
| | Water | 1 | 1977 | 409 | 0.010 |
Why?
| | Haplorhini | 1 | 1973 | 57 | 0.010 |
Why?
| | Heme | 1 | 1973 | 52 | 0.010 |
Why?
| | Mixed Function Oxygenases | 1 | 1973 | 36 | 0.010 |
Why?
| | Neurologic Examination | 1 | 1973 | 115 | 0.010 |
Why?
| | Drug Tolerance | 1 | 1973 | 79 | 0.010 |
Why?
| | Aniline Compounds | 1 | 1973 | 71 | 0.010 |
Why?
| | Antidepressive Agents | 1 | 1974 | 195 | 0.010 |
Why?
| | Methyltransferases | 1 | 1973 | 61 | 0.010 |
Why?
| | Organ Size | 1 | 1973 | 444 | 0.010 |
Why?
| | Phospholipids | 1 | 1973 | 199 | 0.010 |
Why?
| | Suicide | 2 | 1976 | 501 | 0.010 |
Why?
| | Cystic Fibrosis | 1 | 1981 | 957 | 0.010 |
Why?
| | Pre-Eclampsia | 1 | 1973 | 165 | 0.010 |
Why?
| | NADP | 1 | 1971 | 42 | 0.010 |
Why?
| | Plants | 1 | 1973 | 202 | 0.010 |
Why?
| | Chickenpox | 1 | 1972 | 93 | 0.010 |
Why?
| | Safety | 1 | 1993 | 297 | 0.010 |
Why?
| | Glioblastoma | 1 | 1973 | 253 | 0.010 |
Why?
| | Hypoglycemia | 1 | 1975 | 385 | 0.010 |
Why?
| | Body Weight | 1 | 1973 | 873 | 0.010 |
Why?
| | Pulmonary Edema | 2 | 1981 | 116 | 0.000 |
Why?
| | Brain Neoplasms | 2 | 1973 | 984 | 0.000 |
Why?
| | Herpes Zoster | 1 | 1972 | 333 | 0.000 |
Why?
| | Hyperkinesis | 1 | 1987 | 12 | 0.000 |
Why?
| | Monoamine Oxidase Inhibitors | 1 | 1984 | 15 | 0.000 |
Why?
| | Soft Tissue Neoplasms | 1 | 1985 | 90 | 0.000 |
Why?
| | Guinea Pigs | 1 | 1964 | 149 | 0.000 |
Why?
| | Sarcoma | 1 | 1985 | 137 | 0.000 |
Why?
| | Virulence | 1 | 1964 | 228 | 0.000 |
Why?
| | Structure-Activity Relationship | 1 | 1984 | 503 | 0.000 |
Why?
| | Neuromuscular Diseases | 1 | 1984 | 89 | 0.000 |
Why?
| | Foreign-Body Migration | 1 | 1983 | 37 | 0.000 |
Why?
| | Antineoplastic Agents | 1 | 1973 | 1879 | 0.000 |
Why?
| | Rats, Inbred Strains | 1 | 1981 | 376 | 0.000 |
Why?
| | Infant, Low Birth Weight | 1 | 1981 | 125 | 0.000 |
Why?
| | Drug Evaluation, Preclinical | 1 | 1981 | 165 | 0.000 |
Why?
| | Health Occupations | 1 | 1980 | 28 | 0.000 |
Why?
| | Respiration Disorders | 1 | 1981 | 68 | 0.000 |
Why?
| | Biological Availability | 1 | 1980 | 119 | 0.000 |
Why?
| | Skin Absorption | 1 | 1979 | 11 | 0.000 |
Why?
| | Medicine, Traditional | 1 | 1979 | 23 | 0.000 |
Why?
| | Fires | 1 | 1981 | 74 | 0.000 |
Why?
| | Accidents, Occupational | 1 | 1979 | 14 | 0.000 |
Why?
| | Anti-Arrhythmia Agents | 1 | 1979 | 106 | 0.000 |
Why?
| | Electric Stimulation Therapy | 1 | 1979 | 56 | 0.000 |
Why?
| | Shock | 1 | 1979 | 75 | 0.000 |
Why?
| | Gestational Age | 1 | 1981 | 758 | 0.000 |
Why?
| | Podophyllotoxin | 1 | 1978 | 7 | 0.000 |
Why?
| | Heart | 1 | 1982 | 610 | 0.000 |
Why?
| | Condylomata Acuminata | 1 | 1978 | 6 | 0.000 |
Why?
| | Vulvar Neoplasms | 1 | 1978 | 10 | 0.000 |
Why?
| | Pacemaker, Artificial | 1 | 1979 | 107 | 0.000 |
Why?
| | Neoplasms | 1 | 1972 | 2106 | 0.000 |
Why?
| | Administration, Topical | 1 | 1978 | 138 | 0.000 |
Why?
| | Renal Dialysis | 1 | 1981 | 369 | 0.000 |
Why?
| | Neurologic Manifestations | 1 | 1976 | 3 | 0.000 |
Why?
| | Vision Disorders | 1 | 1978 | 130 | 0.000 |
Why?
| | Carbon Radioisotopes | 1 | 1976 | 38 | 0.000 |
Why?
| | Referral and Consultation | 1 | 1980 | 633 | 0.000 |
Why?
| | Mathematics | 1 | 1976 | 101 | 0.000 |
Why?
| | Quality of Health Care | 1 | 1980 | 573 | 0.000 |
Why?
| | Isotope Labeling | 1 | 1976 | 69 | 0.000 |
Why?
| | Recurrence | 1 | 1977 | 941 | 0.000 |
Why?
| | Remission, Spontaneous | 1 | 1973 | 37 | 0.000 |
Why?
| | Blood Platelet Disorders | 1 | 1973 | 10 | 0.000 |
Why?
| | Radionuclide Imaging | 1 | 1973 | 115 | 0.000 |
Why?
| | Astrocytoma | 1 | 1973 | 109 | 0.000 |
Why?
| | Dinitrophenols | 1 | 1972 | 7 | 0.000 |
Why?
| | Complement Fixation Tests | 1 | 1972 | 6 | 0.000 |
Why?
| | Immune Sera | 1 | 1972 | 79 | 0.000 |
Why?
| | Splenectomy | 1 | 1972 | 53 | 0.000 |
Why?
| | Medulloblastoma | 1 | 1973 | 172 | 0.000 |
Why?
| | Ependymoma | 1 | 1973 | 156 | 0.000 |
Why?
| | Neoplasm Metastasis | 1 | 1973 | 524 | 0.000 |
Why?
| | Lymphoma | 1 | 1972 | 178 | 0.000 |
Why?
| | Blood Platelets | 1 | 1973 | 352 | 0.000 |
Why?
| | Hodgkin Disease | 1 | 1972 | 120 | 0.000 |
Why?
| | Leukemia | 1 | 1972 | 209 | 0.000 |
Why?
| | Herpesvirus 3, Human | 1 | 1972 | 380 | 0.000 |
Why?
| | Staphylococcal Infections | 1 | 1972 | 336 | 0.000 |
Why?
| | Chronic Disease | 1 | 1973 | 1591 | 0.000 |
Why?
|
|
Rumack's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|